Solana Company
Helius Medical Technologies: A neurotech company amplifying brain's self-healing through unique, non-invasive technologies.
Founded
2018Helius Medical Technologies: A neurotech company amplifying brain's self-healing through unique, non-invasive technologies.
Helius Medical Technologies, founded with the mission to enhance neurological wellness, focuses on developing, licensing, and acquiring non-invasive platform technologies that amplify the brain's ability to heal itself. Their flagship product, the Portable Neuromodulation Stimulator (PoNSTM), is designed to promote neuroplasticity and improve the lives of individuals suffering from neurological diseases. The company targets the medical device market, specifically addressing neurologic deficits with innovative, non-implantable solutions.
Notable figures affiliated with Helius Medical Technologies include leading experts in neurotechnology and medical device innovation. The company has garnered attention and investment from prominent healthcare investors, reflecting confidence in its pioneering approach. Key achievements include extensive research backing the safety and efficacy of their products, positioning Helius as a significant player in the neurotech field. Their impact is evident in the improved rehabilitation outcomes for patients with neurological conditions, advancing treatment options and enhancing quality of life.
Companies similar to Solana Company include Nexeon Medsystems, Scion Neurostim, Spinex and Nia Therapeutics.
Solana Company was founded in 2018.
Solana Company's headquarters is located in Newtown, PA, US.
Solana Company's most recent funding round was for $18M (USD) in August 2022.
As of Aug 5, 2022, Solana Company has disclosed funding of $96.5M (USD). Undisclosed round amounts are excluded.
Solana Company has 26 employees as of Feb 5, 2024.
Nia Therapeutics
